 |
VitaDX
Allan Rodriguez, CEO
France | Funding: €4.7M (+)
Website: http://vitadx.com/en/
VitaDX is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research.
Website: http://vitadx.com/en/
VitaDX is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research.
